Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup
Aurore Touzart(Inserm), Vahid Asnafi(Hôpital Necker-Enfants Malades)
Cited by 41
Related Papers
A metabolic synthetic lethality of PI3K-driven cancer
|Research Square|2024|0